Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

119.34
Delayed Data
As of Aug 30
 -1.37 / -1.13%
Today’s Change
67.81
Today|||52-Week Range
124.72
+32.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Operating ActivitiesNet Income / Starting Line7.7M10.6M11.0M12.9M
 
 
 
 
 
Depreciation689.0K862.0K1.1M1.4M
 
 
 
 
 
Total Other Cash Flow11.3M7.1M5.1M8.2M
 
 
 
 
 
Funds From Operations24.7M25.1M22.1M29.5M
 
 
 
 
 
Funds From/For Other Operating Expenses6.8M-277.0K-466.0K3.1M
 
 
 
 
 
Net Cash Flow - Operating Activities17.9M25.4M22.6M26.4M
 
 
 
 
 
 
InvestingIncrease In Investments-57.1M-90.6M-71.4M-67.3M
 
 
 
 
 
Decrease In Investments51.2M68.7M49.4M47.1M
 
 
 
 
 
Capital Expenditures-1.6M-4.5M-7.7M-5.1M
 
 
 
 
 
Net Cash Flow Investing-7.5M-26.4M-29.6M-25.3M
 
 
 
 
 
 
FinancingShort Term Borrowings--0.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.8M266.0K2.2M2.8M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing302.0K105.0K3.1M1.0M
 
 
 
 
 
Other Uses - Financing345.0K98.0K3.4M15.0M
 
 
 
 
 
Net Cash Flow - Financing3.8M273.0K1.9M-11.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-280.0K-485.0K183.0K212.0K
 
 
 
 
 
 
Net Change In Cash14.3M-710.0K-5.2M-10.2M